InvestorsHub Logo
Followers 13
Posts 795
Boards Moderated 0
Alias Born 03/03/2010

Re: None

Tuesday, 06/09/2015 9:13:24 AM

Tuesday, June 09, 2015 9:13:24 AM

Post# of 401410
I have a few points to make. Unless I'm mistaken:
* ELI-200's Phase III is just beginning.
* ELI-200 still has to have a successful Phase III. There are no guarantees; not even Nasrat's.
* The FDA works in mysterious ways. So in addition to the challenges of the trial, there are the challenges of getting the FDA to sign off and to do it in a timely fashion.
* Nasrat doesn't have a knack for accurate time estimates and nearly always underestimates. Six months will probably be 9-12 months.
* Until then ELI-200 isn't an actual product.

Yes, this kind of planning is necessary, but they could've inked this deal 6 months ago or 6 months from now ... especially since it's not much different from the left hand shaking hands with the right hand. Said differently Epic Pharma isn't a major pharma.

In the end the announcement is interesting news in a daily-work-a-day kind of way, but this is far from a watershed moment.

Kind regards,
Minding
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News